- Vadim S. Koshkin, MD - Genitourinary Medical Oncology | UCSF Health
In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer
- Vadim Koshkin, MD - UCSF Helen Diller Family Comprehensive Cancer Center
My focus is in clinical and translational research in bladder and prostate cancers, in particular the design and implementation of clinical trials for patients with these malignancies and the discovery and validation of novel biomarkers and treatment targets
- Dr. Vadim S. Koshkin, MD | San Francisco, CA | Oncologist | US News Doctors
Dr Vadim S Koshkin is an oncologist in San Francisco, California and is affiliated with UCSF Health-UCSF Medical Center He received his medical degree from University of Chicago Division of
- Dr. Vadim Koshkin, MD – San Francisco, CA | Oncology - Doximity
Dr Vadim Koshkin, MD is an oncologist in San Francisco, California He is affiliated with UCSF Medical Center
- Vadim S. Koshkin | Oncology | San Francisco, CA | MediFind
Koshkin is highly rated in 14 conditions, according to our data His top areas of expertise are Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, and Lymphadenectomy
- Vadim Koshkin, MD - GU Oncology Now
Dr Vadim Koshkin is a genitourinary medical oncologist at the University of California San Francisco where he leads the bladder cancer clinical program in medical oncology
- Dr. Vadim S Koshkin, 400 Parnassus Avenue, San Francisco CA
Dr Vadim S Koshkin has a medical practice at 400 Parnassus Avenue, San Francisco, CA Dr Vadim S Koshkin specializes in medical oncology and has over 13 years of experience in the field of medicine He is affiliated with numerous hospitals, including Ucsf Medical Center (CA) and more
- Vadim Koshkin, MD | UCSF Division of Hematology and Oncology
Bakshi A, Keck CA, Koshkin VS, LeBold DG, Siman R, Snyder EY, McIntosh TK Caspase-mediated cell death predominates following engraftment of neural progenitor cells into traumatically injured rat brain
|